Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$917M |
| 2 |
Salesforce
CRM
|
+$378M |
| 3 |
Boeing
BA
|
+$297M |
| 4 |
DexCom
DXCM
|
+$292M |
| 5 |
Amazon
AMZN
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DRE
Duke Realty Corp.
DRE
|
+$779M |
| 2 |
Chevron
CVX
|
+$569M |
| 3 |
Home Depot
HD
|
+$292M |
| 4 |
PepsiCo
PEP
|
+$259M |
| 5 |
Chubb
CB
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.22% |
| 2 | Healthcare | 7.51% |
| 3 | Financials | 7.44% |
| 4 | Industrials | 5.79% |
| 5 | Consumer Discretionary | 5.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ATCO
3426
CALL
DELISTED
Atlas Corp.
ATCO
| $2.25M | ﹤0.01% |
146,600
-79,400
| -35% | -$1.2M |
|
3427
Lexicon Pharmaceuticals
LXRX
$1.1B
| $2.25M | ﹤0.01% |
1,176,567
+270,656
| +30% | +$576K |
|
3428
CALL
Globus Medical
GMED
$11.2B
| $2.24M | ﹤0.01% |
30,200
+200
| +0.7% | +$13.6K |
|
3429
Harrow
HROW
$1.51B
| $2.24M | ﹤0.01% |
151,503
+51,689
| +52% | +$618K |
|
|
CHUY
3430
DELISTED
Chuy's Holdings, Inc. Common Stock
CHUY
| $2.24M | ﹤0.01% |
79,011
+59,319
| +301% | +$1.72M |
|
|
CERO
3431
DELISTED
CERo Therapeutics
CERO
| $2.23M | ﹤0.01% |
109
-2
| -2% | -$40.8K |
|
3432
PUT
Match Group
MTCH
$8.55B
| $2.23M | ﹤0.01% |
53,700
-363,400
| -87% | -$16.4M |
|
3433
Northrim BanCorp
NRIM
$587M
| $2.23M | ﹤0.01% |
163,264
-69,904
| -30% | -$882K |
|
|
MASI
3434
CALL
DELISTED
Masimo
MASI
| $2.22M | ﹤0.01% |
15,000
+13,000
| +650% | +$1.79M |
|
|
EXK
3435
Endeavour Silver
EXK
$2.83B
| $2.21M | ﹤0.01% |
683,370
+600,871
| +728% | +$2.02M |
|
|
DCT
3436
DELISTED
Duck Creek Technologies, Inc. Common Stock
DCT
| $2.2M | ﹤0.01% |
182,925
-159,580
| -47% | -$1.83M |
|
3437
Kimco Realty
KIM
$16.4B
| $2.2M | ﹤0.01% |
+104,032
| New | +$2.19M |
|
3438
Sensient Technologies
SXT
$5.53B
| $2.2M | ﹤0.01% |
30,188
+15,137
| +101% | +$1.08M |
|
3439
CALL
Intellia Therapeutics
NTLA
$1.67B
| $2.19M | ﹤0.01% |
+62,700
| New | +$2.98M |
|
3440
American Vanguard Corp
AVD
$68.9M
| $2.19M | ﹤0.01% |
+100,726
| New | +$2.24M |
|
|
ACLX
3441
DELISTED
Arcellx
ACLX
| $2.18M | ﹤0.01% |
70,277
+49,039
| +231% | +$1.12M |
|
3442
Alto Ingredients
ALTO
$340M
| $2.17M | ﹤0.01% |
754,399
-169,997
| -18% | -$604K |
|
3443
Korn Ferry
KFY
$4.28B
| $2.17M | ﹤0.01% |
42,887
-43,804
| -51% | -$2.33M |
|
3444
Kulicke & Soffa
KLIC
$4.78B
| $2.17M | ﹤0.01% |
48,995
-10,430
| -18% | -$458K |
|
|
APEN
3445
CALL
DELISTED
Apollo Endosurgery, Inc.
APEN
| $2.17M | ﹤0.01% |
+217,600
| New | +$1.62M |
|
3446
Coinbase
COIN
$40.5B
| $2.17M | ﹤0.01% |
+61,269
| New | +$3.23M |
|
3447
Business First Bancshares
BFST
$1.03B
| $2.17M | ﹤0.01% |
+97,845
| New | +$2.24M |
|
|
RPC
3448
Ridgepost Capital
RPC
$991M
| $2.16M | ﹤0.01% |
202,763
+15,797
| +8% | +$164K |
|
3449
CALL
Idexx Laboratories
IDXX
$46.2B
| $2.16M | ﹤0.01% |
5,300
-3,700
| -41% | -$1.44M |
|
3450
WhiteHorse Finance
WHF
$146M
| $2.16M | ﹤0.01% |
165,410
+151,457
| +1,085% | +$1.91M |
|
Similar funds
Millennium Management's Q4 2022 Portfolio in Review
As of Q4 2022, Millennium Management held 7,859 positions worth $181B, up 6.9% from $169B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Millennium Management's Q4 2022 filing shows 848 new, 2,517 increased, 2,492 reduced and 1,332 closed positions. Its largest new stake was Keurig Dr Pepper: 4,680,704 shares worth $167M. The largest sale was Duke Realty Corp., an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.9% a quarter earlier, followed by Healthcare and Financials.
- Millennium Management's largest Q4 2022 buy was Keurig Dr Pepper: 4,680,704 shares worth $167M.
- Millennium Management added most to Invesco QQQ Trust in Q4 2022, an estimated $917M increase.
- Millennium Management's biggest Q4 2022 reduction was Chevron, cutting an estimated $569M.
- Millennium Management fully exited Duke Realty Corp. in Q4 2022, selling an estimated $779M.
- Millennium Management's ten largest holdings make up 20% of its $181B portfolio in Q4 2022.
- Millennium Management opened 848 new positions and closed 1,332 in Q4 2022.
- Millennium Management's portfolio value rose 6.9% quarter-over-quarter to $181B.
Based on Millennium Management's 13F filing for Q4 2022, filed 14 Feb 2023.